Over 10,000 Complaints Logged on Ayush Suraksha Portal

1. At a Glance

• Ayush Suraksha is an IT-enabled centralised online portal of the Ministry of Ayush to capture Misleading Advertisements (MLAs)/Objectionable Advertisements (OAs) and Adverse Drug Reactions (ADRs) of Ayush drugs. [S1][S3]
• Launched 30 May 2025; has crossed 10,000+ complaints within ~10 months — a key governance + consumer-protection story in the AYUSH sector. [S1][S3]
• Relevant for GS-II (Governance, Health, Consumer Protection) and GS-III (S&T, regulation of indigenous drug systems).

2. Why in the News

• PIB release dated 20 March 2026 reported that over 10,000 complaints have been logged on the Ayush Suraksha Portal since inception, with all complaints forwarded to concerned State/UT authorities for action. [S1]
• Operationalises the Supreme Court's order dated 30 July 2024 (in the Patanjali misleading ads matter) demanding a centralised dashboard for MLAs/ADRs. [S3]

3. Background & Evolution

• 1954: Drugs and Magic Remedies (Objectionable Advertisements) Act — base statute against exaggerated medicinal claims. [S3]
• 2017: MoU between Ministry of AYUSH and ASCI to co-regulate misleading AYUSH ads. [S2]
• 2024 (July 30): Supreme Court direction (Patanjali case) for a centralised monitoring mechanism. [S3]
• 30 May 2025: Launch of Ayush Suraksha Portal by Ministry of Ayush. [S1][S3]
• March 2026: Cumulative complaints cross 10,000 mark. [S1]

4. Core Static Facts

• Parent ministry: Ministry of Ayush (independent ministry since 2014). [S1]
• Launch date: 30 May 2025. [S1]
• Coverage: MLAs, OAs and ADRs across Ayurveda, Yoga & Naturopathy, Unani, Siddha, Sowa-Rigpa, Homoeopathy. [S1][S3]
• Statutory anchor: Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954; Drugs and Cosmetics Act, 1940; Consumer Protection Act, 2019. [S3]
• Integration: Three-tier Pharmacovigilance Centres under the Pharmacovigilance Programme for ASU&H Drugs, a component of the Central Sector Scheme Ayush Oushadhi Gunvatta evam Uttpadan Samvardhan Yojana (AOGUSY). [S3]
• Forwarding bodies: State/UT Licensing Authorities (Ayush), Ministry of Information & Broadcasting, Central Consumer Protection Authority (CCPA), NCISM, NCH (Homoeopathy), Press Council of India, FSSAI. [S3]
• Trigger ruling: Supreme Court order, 30 July 2024 (Patanjali misleading-ads contempt proceedings). [S3]

5. Multi-Dimensional Analysis

Governance / Administrative - Creates a single-window grievance redress mechanism replacing fragmented complaint channels across state drug controllers. [S3] - Demands inter-ministerial coordination (Ayush ↔ I&B ↔ Consumer Affairs ↔ FSSAI). [S3]

Legal / Constitutional - Operationalises judicial directives under Art. 21 (right to health) and Art. 32 contempt jurisdiction (Patanjali case). [S3] - Strengthens enforcement of the 1954 Magic Remedies Act, long criticised as toothless. [S3]

Social / Consumer Protection - Empowers citizens to flag fraudulent claims on TV, print and digital media. [S1][S3] - Addresses information asymmetry in self-medication of traditional drugs.

Scientific / Pharmacovigilance - Institutionalises ADR reporting for ASU&H drugs — a long-standing scientific gap vis-à-vis allopathic pharmacovigilance under CDSCO/IPC. [S3] - Aligns with the Pharmacovigilance Programme of India (PvPI) philosophy. [S3]

Federal - States/UTs retain licensing power (Concurrent List entry on drugs); portal acts as a forwarding layer, preserving cooperative-federal architecture. [S1]

6. Recent Developments (last 12-18 months)

• 30 July 2024: SC order in Patanjali case mandating centralised dashboard. [S3]
• 30 May 2025: Launch of Ayush Suraksha Portal by Ministry of Ayush. [S1]
• 20 March 2026: PIB confirms 10,000+ registered complaints; all forwarded for action. [S1]
• 2024-25: Pharmacovigilance Programme for ASU&H Drugs continued as component of AOGUSY scheme. [S3]

7. Prelims Hooks

• Ayush Suraksha Portal launched on 30 May 2025. [S1]
• Implementing body: Ministry of Ayush (not Ministry of Health & Family Welfare). [S1]
• Captures MLAs, OAs and ADRs for AYUSH drugs. [S1]
• Built on directions of Supreme Court order dated 30 July 2024 (Patanjali case). [S3]
• Anchor statute: Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. [S3]
• Integrates three-tier Pharmacovigilance Centres of the ASU&H system. [S3]
• Pharmacovigilance Programme for ASU&H is a component of the AOGUSY Central Sector Scheme. [S3]
• Complaints are forwarded to CCPA, MoIB, NCISM, NCH, Press Council of India, FSSAI. [S3]
• Crossed 10,000 complaints by March 2026. [S1]
• ASCI–Ministry of Ayush MoU on co-regulating misleading ads predates the portal. [S2]
• AYUSH systems covered: Ayurveda, Yoga, Naturopathy, Unani, Siddha, Sowa-Rigpa, Homoeopathy. [S3]

8. Mains Relevance

• GS-II: Governance — citizen-centric e-governance; consumer protection; role of regulatory bodies; SC oversight of executive.
• GS-III: Indigenous knowledge systems; drug regulation; S&T (pharmacovigilance).
• Possible question stems: 1. "Examine how the Ayush Suraksha Portal seeks to plug regulatory gaps in the AYUSH sector. What are the institutional bottlenecks?" 2. "Misleading advertisements of medicinal products are a public-health issue, not merely a consumer-protection issue. Discuss in light of recent regulatory initiatives." 3. "Discuss the role of judicial activism in shaping executive accountability, with reference to the Patanjali misleading advertisements case."

9. Related Topics to Study Next

• Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 — anchor law.
• Patanjali Misleading Ads case (2024) — judicial trigger.
• Pharmacovigilance Programme of India (PvPI) — allopathic parallel under IPC, Ghaziabad.
• Central Consumer Protection Authority (CCPA) under Consumer Protection Act, 2019.
• AOGUSY scheme & National AYUSH Mission.
• ASCI (Advertising Standards Council of India) — self-regulation model.
• NCISM & NCH — new AYUSH regulatory commissions (2020 Acts).
• FSSAI regulation of nutraceuticals — overlapping jurisdiction.

10. Common Errors / Trap Areas

• Confusing Ministry of Ayush with Ministry of Health & Family Welfare — Ayush is a separate ministry since 2014. [S1]
• Mixing portal scope: it covers MLAs, OAs and ADRs, not just advertisements.
• Statutory base is the 1954 Magic Remedies Act, not the Consumer Protection Act, 2019 (CPA only supplements).
• Trigger was a Supreme Court order (30 Jul 2024), not a Parliamentary Act.
• Pharmacovigilance for ASU&H sits under AOGUSY, not under PvPI (which is for allopathic drugs).

11. Sources

• [S1] Over 10,000 Complaints Logged on Ayush Suraksha Portal — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2243077 — (tier: 1)
• [S2] Ministry of AYUSH–ASCI MoU on misleading advertisements — https://www.pib.gov.in/newsite/PrintRelease.aspx?relid=157548 — (tier: 1)
• [S3] Ayush Suraksha Portal Launched to Address Misleading Advertisements and ADRs — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2132705 — (tier: 1)